Q-linea AB (publ) (STO:QLINEA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0611
-0.0022 (-3.48%)
Jul 11, 2025, 4:57 PM CET

Q-linea AB Company Description

Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom and European Union.

The company offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, including a sample preparation cartridge and an AST disc, used with the Frozen insert.

It also develops Podler, a portable blood culture unit for incubating and detecting growth in blood bottles.

The company serves physicians, hospitals, laboratories, healthcare payers, and the medical profession.

The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.

Q-linea AB (publ)
Q-linea AB logo
Country Sweden
Founded 2007
Industry Medical Devices
Sector Healthcare
Employees 94
CEO Stuart Gander

Contact Details

Address:
Dag Hammarskjölds väg 52 A
Uppsala, 752 37
Sweden
Phone 46 18 444 3610
Website qlinea.com

Stock Details

Ticker Symbol QLINEA
Exchange Nasdaq Stockholm
Fiscal Year January - December
Reporting Currency SEK
ISIN Number SE0011527845
SIC Code 3845

Key Executives

Name Position
Stuart Gander Chief Executive Officer
Anders Ljunggren Managing Director
Christer Samuelsson Chief Financial Officer and IR
Henrik Jacobson Chief Operating Officer
Ulrika Stolpe HR Manager
Jonas Melin Director Product Development
Thomas Fritz Chief Commercial Officer
Victoria Lerneryd Manager of QA/RA